Efficacy and Safety of Etelcalcetide in Hemodialysis Patients with Moderate to Severe Secondary Hyperparathyroidism
Paola Monciino(University of Milan), Mario Cozzolino(AOL (United States)), Paola Ciceri(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Hoang Nhat Pham(University of Milan), Michela Frittoli(University of Milan), Andrea Stucchi(Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo), Lorenza Magagnoli(AOL (United States)), Chiara Leotta(University of Milan), Andrea Galassi(University of Milan), Eliana Fasulo(Azienda Socio Sanitaria Territoriale Santi Paolo e Carlo)
Cited by 0
Related Papers
37th International Symposium on Intensive Care and Emergency Medicine (part 2 of 3)
|Critical Care|2017|61
Effects of a medium cut-off (Theranova®) dialyser on haemodialysis patients: a prospective, cross-over study
|Clinical Kidney Journal|2019|50
Association between CKD-MBD and mortality in older patients with advanced CKD—results from the EQUAL study
|Nephrology Dialysis Transplantation|2023|37
Choice of the Dialysis Modality: Practical Considerations
|Journal of Clinical Medicine|2023|30
Secondary hyperparathyroidism in chronic kidney disease: pathophysiology, current treatments and investigational drugs
|Expert Opinion on Investigational Drugs|2024|24